|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
3
|
|
gptkbp:bfsParent
|
gptkb:Cipro
|
|
gptkbp:activities
|
broad spectrum
inhibits DNA gyrase
|
|
gptkbp:appointed_by
|
oral tablet
intravenous injection
|
|
gptkbp:approves
|
gptkb:1987
gptkb:FDA
|
|
gptkbp:brand
|
gptkb:Cipro
|
|
gptkbp:category
|
gptkb:C
gptkb:L3
|
|
gptkbp:class
|
gptkb:fluoroquinolone
|
|
gptkbp:clinical_trial
|
Phase IV
Phase III
|
|
gptkbp:contraindication
|
gptkb:Insurance_Company
tendon rupture
|
|
gptkbp:developed_by
|
gptkb:Bayer_AG
|
|
gptkbp:dosage_form
|
500 mg
250 mg
750 mg
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:formulation
|
gptkb:sneaker
gptkb:tablet
suspension
ear drops
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Ciprofloxacin
|
|
gptkbp:indication
|
skin infections
urinary tract infections
gastrointestinal infections
respiratory tract infections
bone and joint infections
|
|
gptkbp:ingredients
|
C17 H18 F N3 O3
|
|
gptkbp:interacts_with
|
gptkb:theophylline
gptkb:warfarin
antacids
|
|
gptkbp:is_atype_of
|
J01 M A02
|
|
gptkbp:is_available_on
|
generic drug
|
|
gptkbp:is_used_for
|
bacterial infections
|
|
gptkbp:lifespan
|
4 hours
|
|
gptkbp:manager
|
IV
oral
|
|
gptkbp:marketed_as
|
gptkb:legislation
gptkb:Australia
gptkb:India
gptkb:United_States
gptkb:Native_American_tribe
|
|
gptkbp:side_effect
|
gptkb:C._difficile_infection
dizziness
headache
nausea
diarrhea
photosensitivity
QT prolongation
hypersensitivity reaction
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:type_of
|
85721-33-1
|
|
gptkbp:weight
|
331.36 g/mol
|